Horizon Therapeutics PLC (NASDAQ:HZNP)

BATS BZX Real-Time Price
As of 3:57pm ET
 -0.26 / -0.97%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Horizon Therapeutics PLC have a median target of 35.00, with a high estimate of 38.00 and a low estimate of 32.00. The median estimate represents a +32.53% increase from the last price of 26.41.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Horizon Therapeutics PLC. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.13%
Growthannually -0.06%


Growthquarterly 3.20%
Growthannually 6.13%
Key to the earnings and sales forecast charts.